Experimental and Clinical Studies on The Therapeutic Effects of Koryo Medicine-Rapid Coronary Blood Flow Enhancer, Atherosclerosis, and Some Ischemic Heart Diseases
DOI:
https://doi.org/10.46966/msjar.v6i4.339Keywords:
Coronary artery, coronary blood flow, arteriosclerosis, angina, Carthami flos, Typhae pollenAbstract
Background and aims: Some Koryo medicines have a very positive effect on cardiovascular diseases such as arteriosclerosis, angina pectoris, myocardial infarction, and acute coronary syndrome by improving coronary blood flow and enhancing cardiac activity. The aim of this study was to investigate the experimental and clinical effects of Koryo medicines, including Carthami flos, Typhae pollen, Ligustici rhizoma, Salviae miltiorrhizae radix, Veratri maximowiczii herba, Epimedii herba, Ginkgo folium, Crataegi fructus, Bupleuri radix, Astragali radix, ivy vine on several cardiovascular diseases. Methods: The composition of "rapid coronary blood flow enhancer": Carthami flos (powder) 0.2, Bupleuri radix (water extract)0.15, Ligustici rhizoma (powder)0.15, Typhae pollen(flour) 0.15, Salviae miltiorrhizae radix(water extract) 0.25, Astragali radix(water extract) 0.25, Veratri maximowiczii herba(water extract) 0.3, Crataegi fructus(powder) 0.3, ivy vine (water extract) 0.3, Epimedii herba(water extract) 0.1, Ginkgo folium(water extract) leaves 0.1 were mixed with honey and prepared by encapsulation to a weight of 0.5g. The experimental animals (Wistar rats) that developed the coronary atherosclerosis model were administered at a dose of 0.6g/kg once daily for 14 days and the experimental parameters were analyzed. Patients with angina pectoris, atherosclerosis, and hypertension were treated with 2 tablet at a time and 3 times a day for 25 days before eating. Results: In coronary atherosclerosis animals and clinical trials, HDL, SOD and CAT activities were significantly elevated, TC, TG, LDL, and LPO levels were significantly decreased (p<0.001), and electrocardiographic findings were significantly improved. Conclusions: The “rapid coronary blood flow enhancer” consisting of several Koryo medicines improves plasma lipids and antioxidant parameters and rapidly relieves clinical symptoms.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 hol Yong Ri, Yong Il Mun, Mae Ri, Chol Ho Kang, Song Thaek O
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
